Waters | WAT - Ebitda

股票价格
304.24
每天变化
4.35 1.45%
每月一次
-2.53%
每年
-11.85%
Q2 预测
295.08


金融业
股票价格
USD
资产
USD 5.08B
现金及等价物
USD 587.83M
销售成本
USD 374.94M
流动资产
USD 1.99B
流动负债
USD 1.24B
债务
USD 1.49B
EBIT
USD 270.52M
EBITDA
USD 380.97M
员工
7.6K
EPS每股收益
USD 4.53
股本和储备
USD 2.56B
销售毛利
USD 557.42M
债务利息支出
USD 8.62M
利息收入
USD 2.5
贷款资金
USD 1.41B
市值
USD 18.01B
净收入
USD 225.21M
营业费用
USD 661.85M
营业利润
USD 270.52M
普通股股本
USD 98.08M
PE价格收益
35.29
税前利润
USD 170.12M
销售收入
USD 932M
销售和管理费用
USD 240.01M
股票
USD 572.37M
贸易债权人
USD 103.78M
应收帐款人
USD 828.84M


Ebitda 更改 日
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Bio Techne USD 103.42M 7.47M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Danaher USD 2.13B 252M 2025-12
Dentsply International USD 135M 32M 2025-12
General Electric Aerospace USD 3.04B 185M 2025-09
Hologic USD 330.4M 16.6M 2025-12
Illumina USD 332M 12M 2025-09
Intuitive Surgical USD 919.7M 21M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
Merck USD 8.39B 1.97B 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Quest Diagnostics USD 537M 24M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Veracyte USD 42.31M 2.58M 2025-12
Waters USD 380.97M 85.83M 2025-12